Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 +0.010 (+0.33%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
August 24, 2017
Form 4
Source: SEC/Edgar
July 04, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
March 16, 2017
Form 4
Source: SEC/Edgar
January 29, 2017
Form 4
Source: SEC/Edgar
January 29, 2017
Form 4
Source: SEC/Edgar
January 29, 2017
Form 4
Source: SEC/Edgar
January 02, 2017
Form 4
Source: SEC/Edgar
December 29, 2016
Form 4
Source: SEC/Edgar
December 15, 2016
Form 4
Source: SEC/Edgar
November 24, 2016
Form 4
Source: SEC/Edgar
October 27, 2016
Form 4
Source: SEC/Edgar
August 15, 2016
Form 3
Source: SEC/Edgar
July 05, 2016
Form 4
Source: SEC/Edgar
July 05, 2016
Form 4
Source: SEC/Edgar
July 04, 2016
Form 4
Source: SEC/Edgar
June 14, 2016
Form 4
Source: SEC/Edgar
May 22, 2016
Form 4
Source: SEC/Edgar
May 22, 2016
Form 4
Source: SEC/Edgar
May 22, 2016
Form 4
Source: SEC/Edgar
May 10, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
May 08, 2016
Form 4
Source: SEC/Edgar
April 12, 2016
Form 4
Source: SEC/Edgar
March 08, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.